Financhill
Buy
56

CSTL Quote, Financials, Valuation and Earnings

Last price:
$39.39
Seasonality move :
-8.42%
Day range:
$39.28 - $39.97
52-week range:
$14.59 - $42.18
Dividend yield:
0%
P/E ratio:
30.24x
P/S ratio:
3.37x
P/B ratio:
2.46x
Volume:
187K
Avg. volume:
418.2K
1-year change:
45.37%
Market cap:
$1.1B
Revenue:
$332.1M
EPS (TTM):
-$0.45

Earnings Data

Next earnings date for CSTL
Feb 26
2026
Most recent earnings per share
-$0.02
Beat by $0.49
(Nov 3/2025)
Consensus Estimate
-$0.51
(Nov 3/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CSTL Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/26/2026 Q4 $76.4M -- -- -$0.34 --
11/03/2025 Q3 $71.1M $83M -$0.02 -$0.51 $0.49
08/04/2025 Q2 $71.4M $86.2M $0.15 -$0.50 $0.65
05/05/2025 Q1 $80.4M $88M -$0.90 -$0.07 -$0.84
02/27/2025 Q4 $83.9M $86.3M $0.32 $0.04 $0.28
11/04/2024 Q3 $79M $85.8M $0.08 $0.01 $0.07
08/05/2024 Q2 $69.4M $87M $0.31 -$0.25 $0.56
05/02/2024 Q1 $66.2M $73M -$0.09 -$0.31 $0.22
02/28/2024 Q4 $61.2M $66.1M -$0.09 -$0.49 $0.40
11/02/2023 Q3 -- -- -$0.26 -$0.73 $0.47
08/02/2023 Q2 -- -- -$0.70 -$0.91 $0.21
05/03/2023 Q1 -- -- -$1.10 -$0.89 -$0.21
02/28/2023 Q4 -- -- -$0.78 -$0.83 $0.05
11/02/2022 Q3 -- -- -$0.77 -$0.97 $0.20
08/08/2022 Q2 -- -- -$0.06 -$0.80 $0.74
05/09/2022 Q1 -- -- -$0.97 -$0.74 -$0.23
02/28/2022 Q4 -- -- -$0.25 -$0.47 $0.22
11/08/2021 Q3 -- -- -$0.47 -$0.37 -$0.10
08/09/2021 Q2 -- -- -$0.35 -$0.39 $0.04
05/10/2021 Q1 -- -- -$0.17 -$0.19 $0.02
03/08/2021 Q4 -- -- -$0.23 -$0.11 -$0.12
11/09/2020 Q3 -- -- -$0.23 -$0.16 -$0.08
08/10/2020 Q2 -- -- -$0.08 -$0.44 $0.36
05/11/2020 Q1 -- -- $0.03 -$0.05 $0.08
03/10/2020 Q4 -- -- $0.11 -$0.02 $0.13
11/11/2019 Q3 -- -- $0.05 -$0.30 $0.35
09/03/2019 Q2 -- -- -$0.15 -$0.47 $0.32
03/31/2019 Q1 -- -- -$0.22 -- --
12/31/2018 Q4 -- -- $0.27 -- --
09/30/2018 Q3 -- -- -$0.42 -- --
06/30/2018 Q2 -- -- -$0.38 -- --
03/31/2018 Q1 -- -- -$0.42 -- --

Castle Biosciences, Inc. Earnings Questions

  • How Much did Castle Biosciences, Inc. Generate in Revenue Last Quarter?

    Castle Biosciences, Inc. reported $83M worth of top line sales in its most recent quarter.

  • Did Castle Biosciences, Inc. Beat Earnings Last Quarter?

    Castle Biosciences, Inc. announced earnings per share of -$0.02 which represents a beat of analyst forecast a -$0.51 per share.

  • Is Castle Biosciences, Inc. Profitable?

    Castle Biosciences, Inc. reported $61.5M that represents $2.12 per share over the last quarter.

  • What is the Analyst Consensus for Castle Biosciences, Inc. EPS Next Year?

    Castle Biosciences, Inc.'s earnings are forecast to decrease from $0.62 per share to -$0.90 per share next year representing a decrease of -75.68%.

  • When is Castle Biosciences, Inc.'s Earnings Date?

    Castle Biosciences, Inc.'s next earnings date is February 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
72
GLTO alert for Dec 27

Galecto, Inc. [GLTO] is up 16.92% over the past day.

Sell
20
SMX alert for Dec 27

SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.

Sell
11
CDNAF alert for Dec 27

Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock